Anti-CHPT1 monoclonal antibody

Pre-made anti-CHPT1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CHPT1/CHPT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0543-Ab-1/ GM-Tg-hg-IP0543-Ab-2Anti-Human CHPT1 monoclonal antibodyHuman
GM-Tg-rg-IP0543-Ab-1/ GM-Tg-rg-IP0543-Ab-2Anti-Rat CHPT1 monoclonal antibodyRat
GM-Tg-mg-IP0543-Ab-1/ GM-Tg-mg-IP0543-Ab-2Anti-Mouse CHPT1 monoclonal antibodyMouse
GM-Tg-cynog-IP0543-Ab-1/ GM-Tg-cynog-IP0543-Ab-2Anti-Cynomolgus/ Rhesus macaque CHPT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0543-Ab-1/ GM-Tg-felg-IP0543-Ab-2Anti-Feline CHPT1 monoclonal antibodyFeline
GM-Tg-cang-IP0543-Ab-1/ GM-Tg-cang-IP0543-Ab-2Anti-Canine CHPT1 monoclonal antibodyCanine
GM-Tg-bovg-IP0543-Ab-1/ GM-Tg-bovg-IP0543-Ab-2Anti-Bovine CHPT1 monoclonal antibodyBovine
GM-Tg-equg-IP0543-Ab-1/ GM-Tg-equg-IP0543-Ab-2Anti-Equine CHPT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0543-Ab-1/ GM-Tg-hg-IP0543-Ab-2; GM-Tg-rg-IP0543-Ab-1/ GM-Tg-rg-IP0543-Ab-2;
GM-Tg-mg-IP0543-Ab-1/ GM-Tg-mg-IP0543-Ab-2; GM-Tg-cynog-IP0543-Ab-1/ GM-Tg-cynog-IP0543-Ab-2;
GM-Tg-felg-IP0543-Ab-1/ GM-Tg-felg-IP0543-Ab-2; GM-Tg-cang-IP0543-Ab-1/ GM-Tg-cang-IP0543-Ab-2;
GM-Tg-bovg-IP0543-Ab-1/ GM-Tg-bovg-IP0543-Ab-2; GM-Tg-equg-IP0543-Ab-1/ GM-Tg-equg-IP0543-Ab-2
Products NameAnti-CHPT1 monoclonal antibody
Formatmab
Target NameCHPT1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CHPT1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0543-Ag-1Recombinant multi-species CHPT1/ CPT/ CPT1 protein
    ORF Viral VectorvGMLP002617human CHPT1 Lentivirus particle
    ORF Viral VectorpGMLP002617human CHPT1 Lentivirus plasmid
    ORF Viral VectorpGMLPm005259mouse Chpt1 Lentivirus plasmid
    ORF Viral VectorvGMLPm005259mouse Chpt1 Lentivirus particle


    Target information

    Target IDGM-IP0543
    Target NameCHPT1
    Gene ID56994,212862,362866,696056,610214,101099986,511291,106782693
    Gene Symbol and SynonymsCHPT1,CPT,CPT1
    Uniprot AccessionQ8WUD6,Q66H21,Q1LZE6
    Uniprot Entry NameCHPT1_HUMAN,CHPT1_RAT,CHPT1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000111666
    Target ClassificationN/A

    The target: CHPT1, gene name: CHPT1, also named as CPT, CPT1. Enables diacylglycerol cholinephosphotransferase activity. Involved in phosphatidylcholine biosynthetic process and platelet activating factor biosynthetic process. Predicted to be located in Golgi membrane. Predicted to be active in Golgi apparatus and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.